Adebrelimab + Chemotherapy as Neoadjuvant Therapy for Resectable NSCLC
Clinical trial NCT07035392 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07035392
- Sponsor
- Zhangzhou Municipal Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-20
- Primary completion
- 2026-12-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.